TLPLDC

Initial Ph II 2b Results of Elios' Personalized Cancer Vaccine for the Treatment of Melanoma Look Promising
CP Wire
Wed, 04/18/18 - 09:35 am
Elios Therapeutics
vaccines
melanoma
AACR
clinical trials
TLPLDC